CN104873854A - 一种用于小动脉性肾硬化症的中药制剂及其制备方法 - Google Patents
一种用于小动脉性肾硬化症的中药制剂及其制备方法 Download PDFInfo
- Publication number
- CN104873854A CN104873854A CN201510335673.7A CN201510335673A CN104873854A CN 104873854 A CN104873854 A CN 104873854A CN 201510335673 A CN201510335673 A CN 201510335673A CN 104873854 A CN104873854 A CN 104873854A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- preparation
- chinese medicine
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 201000009925 nephrosclerosis Diseases 0.000 title claims abstract description 27
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 13
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims description 33
- 241000237903 Hirudo Species 0.000 claims description 13
- 241000628997 Flos Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 238000001802 infusion Methods 0.000 claims description 12
- 241000190633 Cordyceps Species 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 53
- 210000004369 blood Anatomy 0.000 abstract description 51
- 210000003734 kidney Anatomy 0.000 abstract description 42
- 230000000694 effects Effects 0.000 abstract description 40
- 210000004185 liver Anatomy 0.000 abstract description 38
- 230000001737 promoting effect Effects 0.000 abstract description 26
- 230000017531 blood circulation Effects 0.000 abstract description 19
- 230000002175 menstrual effect Effects 0.000 abstract description 8
- 230000004087 circulation Effects 0.000 abstract description 5
- 235000006533 astragalus Nutrition 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 241000045403 Astragalus propinquus Species 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 238000000034 method Methods 0.000 abstract description 3
- 244000144730 Amygdalus persica Species 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 2
- 241000110637 Cuscuta chinensis Species 0.000 abstract description 2
- 241000112528 Ligusticum striatum Species 0.000 abstract description 2
- 241001248610 Ophiocordyceps sinensis Species 0.000 abstract description 2
- 244000292697 Polygonum aviculare Species 0.000 abstract description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 abstract description 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241000207925 Leonurus Species 0.000 abstract 1
- 244000241872 Lycium chinense Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 24
- 235000019634 flavors Nutrition 0.000 description 24
- 208000002193 Pain Diseases 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 16
- 229940079593 drug Drugs 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 14
- 201000000736 Amenorrhea Diseases 0.000 description 13
- 206010001928 Amenorrhoea Diseases 0.000 description 13
- 210000001015 abdomen Anatomy 0.000 description 13
- 231100000540 amenorrhea Toxicity 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000006378 damage Effects 0.000 description 12
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- 230000027939 micturition Effects 0.000 description 10
- 208000005171 Dysmenorrhea Diseases 0.000 description 9
- 206010013935 Dysmenorrhoea Diseases 0.000 description 9
- 230000005906 menstruation Effects 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 210000001367 artery Anatomy 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000001939 inductive effect Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 241000721047 Danaus plexippus Species 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 208000019255 Menstrual disease Diseases 0.000 description 5
- 208000025747 Rheumatic disease Diseases 0.000 description 5
- 230000036285 pathological change Effects 0.000 description 5
- 231100000915 pathological change Toxicity 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 230000000552 rheumatic effect Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 201000001881 impotence Diseases 0.000 description 4
- 230000003907 kidney function Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 201000001474 proteinuria Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010067482 No adverse event Diseases 0.000 description 3
- 206010059013 Nocturnal emission Diseases 0.000 description 3
- 206010030302 Oliguria Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000001434 glomerular Effects 0.000 description 3
- 230000001631 hypertensive effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000005239 tubule Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 240000007171 Imperata cylindrica Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 2
- 208000034777 Vitreous degeneration Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 210000002565 arteriole Anatomy 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 208000020832 chronic kidney disease Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000028208 end stage renal disease Diseases 0.000 description 2
- 201000000523 end stage renal failure Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000004761 fibrosis Effects 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 206010061989 glomerulosclerosis Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 231100001028 renal lesion Toxicity 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 201000011288 vitreous syneresis Diseases 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 240000000031 Achyranthes bidentata Species 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000214021 Astragalus complanatus Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241000221751 Claviceps purpurea Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000241463 Cullen corylifolium Species 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000123586 Dipsacaceae Species 0.000 description 1
- 241000729170 Dipsacus asper Species 0.000 description 1
- 241001050741 Dipsacus asperoides Species 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000130660 Hepialidae Species 0.000 description 1
- 241000237678 Hirudinidae Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000003271 Leonurus japonicus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000244365 Ligusticum sinense Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 241000729196 Lycopus lucidus Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000008763 Mercury poisoning Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 241000124464 Paeonia veitchii Species 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 241001404789 Smilax glabra Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 241001431359 Whitmania acranulata Species 0.000 description 1
- 241000258623 Whitmania pigra Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 1
- 229960000830 captopril Drugs 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于小动脉性肾硬化症的中药制剂,它是以桃仁、红花、当归、菟丝子、枸杞子、赤芍、川芎、丹参、益母草、三七粉、黄芪、白茅根、土茯苓、川牛膝、冬虫夏草、水蛭、沙苑子、续断、补骨脂、桂枝、萹蓄、泽兰、炙甘草为原料,属于中药发明领域。根据每味中药的不同特性,以洗净切块预处理后,按比例配制,经特殊方法制作,具有滋补肝肾、助阳益精、活血调经、行气逐瘀的作用,本发明产品组合及制作方法独特,经临床验证,该药治疗效果显著,治疗周期短,价格低廉,无不良反应和任何毒副作用,具有广阔的市场应用前景。
Description
技术领域
本发明涉及一种中药制剂,具体涉及一种用于小动脉性肾硬化症的中药制剂,本发明还涉及该中药制剂的制备方法。
背景技术
小动脉性肾硬化症,为西方国家导致终末期肾衰竭的第二位疾病 ( 约占 25%),我国发病率也在日益增多。本病可分为良性小动脉性肾硬化症 (benign arteriolar nephrosclerosis) 及恶性小动脉性肾硬化症 (malignant arteriolar nephrosclerosis) 两种。小动脉性肾硬化症主要侵犯肾小球前小动脉,导致入球小动脉玻璃样变,小叶间动脉及弓状脉肌内膜增厚。如此即造成动脉管腔狭窄,供血减少,进而继发缺血性肾实质损害,致成肾小球硬化、肾小管萎缩及肾间质纤维化。此病发病机理是由长期未控制好的良性高血压引起,高血压持续 5~10 年即可能出现良性小动脉肾硬化症的病理改变,10~15年即可能出现临床表现,本病主要侵犯肾小球前小动脉,导致入球小动脉玻璃样变,小叶间动脉及弓状动脉肌内膜增厚。如此即造成动脉管腔狭窄,供血减少,进而继发缺血性肾实质损害,致成肾小球硬化、肾小管萎缩及肾间质纤维化。
中医学认为,本病主证以虚损为主,同时可兼有外邪、水湿及瘀血,呈虚中挟实之证。“精气夺则虚”,由于脾肾在人身之重要作用,久病虚候,也以脾肾见证为多,若肾阴不足,水不涵木,肝失所养,见肝肾阴虚的表现。病至后期,脾肾衰败,湿浊内阻,下关上格,见少尿呕恶纳少。
发明内容
本发明的目的在于提供一种用于小动脉性肾硬化症的中药制剂,该中药制剂对于治疗小动脉性肾硬化症具有治疗效果显著,治愈时间短,价格低廉,无不良反应和副毒作用的特点。
发明人在多年的临床医疗实践中,根据该病症的发展规律,以及中药的配伍原则,并通过大量的临床验证,反复探索总结出用于治疗小动脉性肾硬化症的中药制剂的新配方。本发明具有治疗效果显著,治愈时间短,价格低廉,无不良反应和副毒作用的特点。
本发明中药物的作用:
其中:
桃仁:为蔷薇科植物桃Prunus persica (L.) Batsch 或山桃 Prunus davidiana (Carr.)Franch.的干燥成熟种子。性味:苦、甘,平。归心、肝、大肠经。功效:活血祛瘀,润肠通便。用于经闭,痛经,癓瘕痞块,跌扑损伤,肠燥便秘。《本经》中记载:主瘀血,血闭症瘕,邪气,杀小虫。《别录》:止咳逆上气,消心下坚,除卒暴击血,破症瘕,通脉,止痛。
红花:为菊科植物红花Carthamus tinctorius L.的干燥花。性味:辛,温。归心、肝经。功效:活血通经,散瘀止痛。用于经闭,痛经,恶露不行,症瘕痞块,跌扑损伤,疮疡肿痛。《纲目》:活血,润燥,止痛,散肿,通经。
当归:为伞形科植物当归Angelica sinensis (Oliv.) Diels 的干燥根。性味:甘、辛,温。归肝、心、脾经。功效:补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,月经不调,经闭痛经,虚寒腹痛,肠燥便秘,风湿痹痛,跌扑损伤,痈疽疮疡。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。《日华子本草》中记载:治一切风,一切血,补一切劳,破恶血,养新血及主癥癖。
菟丝子:为旋花科植物菟丝子Cuscuta chinensis Lam. 的干燥成熟种子。性味:甘,温。归肝、肾、脾经。功效:滋补肝肾,固精缩尿,安胎,明目,止泻。用于阳痿遗精,尿有余沥,遗尿尿频,腰膝酸软,目昏耳鸣,肾虚胎漏,胎动不安,脾肾虚泻;外治白癜风。《别录》中记载:养肌强阴,坚筋骨,主茎中寒,精自出,溺有余沥,口苦燥渴,寒血为积。
枸杞子:为茄科植物宁夏枸杞Lycium barbarum L. 的干燥成熟果实。性味:甘,平。归肝、肾经。功效:滋补肝肾,益精明目。用于虚劳精亏,腰膝酸痛,眩晕耳鸣,内热消渴,血虚萎黄,目昏不明。《食疗本草》中记载:坚筋耐老,除风,补益筋骨,能益人,去虚劳。
赤芍:为毛茛科植物芍药Paeonia lactiflora Pall.或川赤芍Paeonia veitchii Lynch 的干燥根。性味:苦,微寒。归肝经。功效:清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。陶弘景曰:“芍药赤者小利,俗方以止痛,乃不减当归。
川芎:为伞形科植物川芎Ligusticum chuanxiong Hort.(或Ligusticum wallichii Franch.)的干燥根茎。性味:辛,温。归肝、胆、心包经。功效:活血行气,祛风止痛。用于月经不调,经闭痛经,症瘕腹痛,胸胁刺痛,跌扑肿痛,头痛,风湿痹痛。《日华子本草》中记载:治一切风,一切气,一切劳损,一切血,补五劳,壮筋骨,调众脉,破癥结宿血,养新血,长肉,鼻洪,吐血及溺血,痔瘘,脑痈发背,瘰疬瘿赘,疮疥,及排脓消瘀血。
丹参:为唇形科植物丹参Salvia miltiorrhiza Bunge. 的干燥根及根茎。性味:苦,微寒。归心、肝经。功效:祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠;肝脾肿大,心绞痛。《滇南本草》中记载:补心定志,安神宁心。治健忘怔冲,惊悸不寐。
益母草:为唇形科植物益母草Leonurus japonicus Houtt. 的新鲜或干燥地上部分。性味:苦、辛,微寒。归肝、心包经。功效:活血调经,利尿消肿。用于月经不调,痛经,经闭,恶露不尽,水肿尿少;急性肾炎水肿。
三七:为五加科植物三七Panax notoginseng (Burk.)F. H. Chen的干燥根。性味:甘、微苦,温。归肝、胃经。功效:散瘀止血,消肿定痛。用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹剌痛,跌扑肿痛。《玉揪药解》中记载:"和营止血,通脉行瘀,行瘀血而敛新血。
黄芪:为豆科植物蒙古黄芪 Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.)Hsiao 或膜荚黄芪 Astragalus membranaceus (Fisch.) Bge.的干燥根。性味:甘,温。归肺、脾经。功效:补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,痈疽难溃,久溃不敛,血虚痿黄,内热消渴;慢性肾炎蛋白尿,糖尿病。
白茅根:为禾本科植物白茅Imperata cylindrica Beauv. var. major (Nees)C. E. Hubb. 的干燥根茎。性味:甘,寒。归肺、胃、膀胱经。
功效:凉血止血,清热利尿。用于血热吐血,衄血,尿血,热病烦渴,黄疸,水肿,热淋涩痛;急性肾炎水肿。
土茯苓:为百合科植物光叶菝葜Smilax glabra Roxb.的干燥根茎。性味:甘、淡,平。归肝、胃经。功效:除湿,解毒,通利关节。用于湿热淋浊,带下,痈肿,瘰疬,疥癣,梅毒及汞中毒所致的肢体拘挛,筋骨疼痛。《本草正》中记载:疗痈肿、喉痹,除周身寒湿、恶疮。
川牛膝:为四川苋科植物牛膝Achyranthes bidentata Blume. 的干燥根。性味:苦、酸,平。归肝、肾经。功效: 逐瘀通经,通利关节,利尿通淋。用于经闭症瘕,胞衣不下,关节痹痛,足痿筋挛,尿血血淋,跌扑损伤。《四川中药志》中记载:祛风利湿,通经散血。治寒湿腰腿骨痛,足痿筋挛,妇女经闭及症瘕,淋病,尿血,阴痿、失溺。
冬虫夏草:为麦角菌科真菌冬虫夏草菌Cordyceps sinensis (Berk.)Sacc. 寄生在蝙蝠蛾科昆虫幼虫上的子座及幼虫尸体的复合体。性味:甘,平。归肺、肾经。功效:补肺益肾,止血化痰。用于久咳虚喘,劳嗽咯血,阳痿遗精,腰膝酸痛。《药性考》中记载:秘精益气,专补命门。
水蛭:为水蛭科动物蚂蟥Whitmania pigra Whitman、水蛭Hirudo nipponica Whitman或柳叶蚂蟥Whit-mania acranulata Whitman 的干燥体。性味:咸、苦,平;有小毒。归肝经。功效:破血,逐瘀,通经。用于症瘕痞块,血瘀经闭,跌扑损伤。
沙苑子:为豆科植物扁茎黄芪Astragalus complanatus R.Brown.的干燥成熟种子。性味:甘,温。归肝、肾经。功效:温补肝肾,固精,缩尿,明目。用于肾虚腰痛,遗精早泄,白浊带下,小便余沥,眩晕目昏。
续断:为川续断科植物川续断Dipsacus asperoides C. Y. Cheng et T. M. Ai (或Dipsacus asper Wall)的干燥根。性味:苦、辛,微温。归肝、肾经。功效:补肝肾,强筋骨,续折伤,止崩漏。用于腰膝酸软,风湿痹痛,崩漏,胎漏,跌扑损伤。酒续断多用于风湿痹痛,跌扑损伤。盐续断多用于腰膝酸软。《本经》中记载:主伤寒,补不足,金疮,痈疡,折跌,续筋骨,妇人乳难,久服益气力。
补骨脂:为豆科植物补骨脂Psoralea corylifolia L. 的干燥成熟果实。性味:辛、苦,温。归肾、脾经。功效:温肾助阳,纳气,止泻。用于阳痿遗精,遗尿尿频,腰膝冷痛,肾虚作喘,五更泄泻;外用治白癜风,斑秃。《玉楸药解》中记载:温暖水土,消化饮食,升达脾胃,收敛滑泄、遗精、带下、溺多、便滑诸证。
桂枝:为樟科植物肉桂 Cinnamomum cassia Presl的干燥嫩枝。春、夏二季采收,除去叶,晒干,或切片晒干。性味:辛、甘,温。归心、肺、膀胱经。主治发汗解肌,温通经脉,助阳化气,平冲降气。用于风寒感冒,脘腹冷痛,血寒经闭,关节痹痛,痰饮,水肿,心悸,奔豚。
萹蓄:为蓼科植物萹蓄 Polygonum aviculare L. 的干燥地上部分。性味:苦,微寒。归膀胱经。功效:利尿通淋,杀虫,止痒。用于膀胱热淋,小便短赤,淋沥涩痛,皮肤湿疹,阴痒带下。《本经》中记载:主浸淫,疥瘙疽痔,杀三虫。
泽兰:为唇形科植物毛叶地瓜儿苗Lycopus lucidus Turcz. var.hirtus Regel的干燥地上部分。夏、秋季茎叶茂盛时采割,晒干。性味:苦、辛,微温。归肝、脾经。功效:活血化瘀,行水消肿。用于月经不调,经闭,痛经,产后瘀血腹痛,水肿。《日华子本草》中记载:通九窍,利关脉,养血气,破宿血,消症瘕。
炙甘草:为甘草的炮制加工品。性味:甘,平。归心、肺、脾、胃经 。功效:补脾和胃,益气复脉。用于脾胃虚弱,倦怠乏力,心动悸,脉结代。
本发明的方解是:方中菟丝子滋补肝肾、固精缩尿,枸杞子滋补肝肾、益精明目,冬虫夏草补肺益肾、止血化痰,续断、沙苑子温补肝肾,补骨脂温肾助阳,以上六味药作为方中君药,均归肾经,具有滋补肝肾、助阳益精的作用。中医学认为,本病主证以虚损为主,同时可兼有外邪及瘀血,“精气夺则虚”,由于脾肾在人身之重要作用,久病虚候而引发本病。所以滋补肝肾、助阳益精是治疗小动脉性肾硬化症的基础,以上六味药均为君药,首先从根本上滋补肝肾、助阳益精,使病症得到根本的控制。桃仁活血祛瘀,丹参、红花活血通经,益母草、当归活血调经,赤芍散瘀止疼,川芎活血行气,三七粉散瘀止血,川牛膝逐瘀通经,水蛭逐瘀通经,,以上十味药为方中臣药,归肝经。中医讲肝肾同源,生理病理密切相关,在病症上采用“肾肝同治” 的治疗法则。在先天,肝肾共同起源于生殖之精;在后天,肝肾共同受肾所藏的先后天综合之精的充养。一方面辅助君药滋补肝肾、助阳益精的功效;另一方面作为臣药具有活血调经、行气逐瘀的功效。黄芪补气固表、利尿托毒,白茅根清热利尿,土茯苓除湿利尿,桂枝温通经脉,萹蓄利尿通淋,泽兰活血化瘀、行水消肿,以上六味药归脾、胃经,作为佐药,从病理上治疗引起小动脉性肾硬化症的诱因,作为佐药既能促进君臣二药的滋补肝肾、助阳益精的功效,又能反佐君臣二药促进机体活血调经、行气逐瘀的作用。炙甘草作为方中使药,具有调和诸药、调和药味的作用,此方诸药合用,君臣协力,佐使共辅,具有滋补肝肾、助阳益精、活血调经、行气逐瘀的功效,能够有效治疗小动脉性肾硬化症。
本发明另一个重要特点是该中药制剂含有丰富的营养成分,富含氨基酸有17种以上,其中人体必需氨基酸有苏氨酸、缬氨酸、蛋氨酸、异亮氨酸、亮氨酸、赖氨酸和苯丙氨酸,含有人体必需的微量元素有铁、铬、铜、硼、锰、锶、和锌,另含钙、钾、镁、磷几种人体宏量元素。以上营养成分都是人体必需物质,能有效增强人体免疫力。
本发明药物原料用量是经发明人进行大量摸索总结得出的,各原料用量为在下述重量份范围都具有较好的疗效:桃仁10-14份、红花9-7-11份、当归16-20份、菟丝子18-22份、枸杞子18-22份、赤芍13-17份、川芎13-17份、丹参22-26份、益母草13-20份、三七粉1-5份、黄芪28-32份、白茅根22-26份、土茯苓16-20份、川牛膝13-17份、冬虫夏草1-5份、水蛭4-8份、沙苑子13-17份、续断18-22份、补骨脂16-20份、桂枝13-17份、萹蓄16-20份、泽兰13-17份、炙甘草7-11份。
其中优选为:桃仁12份、红花9份、当归18份、菟丝子20份、枸杞子20份、赤芍15份、川芎15份、丹参24份、益母草18份、三七粉3份、黄芪30份、白茅根24份、土茯苓18份、川牛膝15份、冬虫夏草3份、水蛭6份、沙苑子15份、续断20份、补骨脂18份、桂枝15份、萹蓄18份、泽兰15份、炙甘草9份。
一种用于小动脉性肾硬化症的中药制剂的制备方法如下:
步骤一:按本发明重量份配比,取三七粉,粉碎,过200目筛,备用;
步骤二:按本发明重量份配比,取冬虫夏草放入容器中,加入3倍体积的水,武火熬煮40-50分钟后,转文火熬煮10-20分钟,过滤滤液,反复三次,合并滤液,备用;
步骤三:按本发明重量配比,取枸杞子、赤芍、丹参、黄芪、白茅根、土茯苓、川牛膝、水蛭、续断、桂枝、萹蓄、泽兰、炙甘草药材置于砂锅中,加入8倍体积的水,武火熬煮20-30分钟后,加入红花、当归、川芎、益母草、补骨脂及分别用纱布包扎好的沙苑子、桃仁、菟丝子,武火熬煮10-20分钟,转文火熬煮30~40分钟得滤液,反复熬煮三次合并所得滤液,备用;
步骤四:将步骤二、三所得滤液趁热冲服步骤一所得粉末,搅匀,既得本发明所述的治疗小动脉性肾硬化症的汤剂。
本发明使用方法:取汤剂,饭后一小时内服用,每天三次。
本发明药物具有滋补肝肾、助阳益精、活血调经、行气逐瘀的作用,且止痛效果好,价格低廉,无毒副作用,使用方便,该中药制剂采用的方式治疗可以减少西药对患者身体的伤害,减轻患者的病痛,据对临床240例患者观察统计,使用本发明药物一个疗程总有效率82.5%,两个疗程总有效率95%。
具体实施方式
实施例一:桃仁12份、红花9份、当归18份、菟丝子20份、枸杞子20份、赤芍15份、川芎15份、丹参24份、益母草18份、三七粉3份、黄芪30份、白茅根24份、土茯苓18份、川牛膝15份、冬虫夏草3份、水蛭6份、沙苑子15份、续断20份、补骨脂18份、桂枝15份、萹蓄18份、泽兰15份、炙甘草9份。
实施例二:桃仁11份、红花10份、当归17份、菟丝子21份、枸杞子20份、赤芍15份、川芎16份、丹参24份、益母草18份、三七粉4份、黄芪31份、白茅根23份、土茯苓18份、川牛膝15份、冬虫夏草4份、水蛭6份、沙苑子16份、续断20份、补骨脂18份、桂枝16份、萹蓄18份、泽兰15份、炙甘草10份。
实施例三:桃仁13份、红花10份、当归19份、菟丝子20份、枸杞子21份、赤芍14份、川芎14份、丹参24份、益母草19份、三七粉3份、黄芪31份、白茅根25份、土茯苓18份、川牛膝15份、冬虫夏草3份、水蛭7份、沙苑子16份、续断20份、补骨脂18份、桂枝16份、萹蓄18份、泽兰15份、炙甘草10份。
就下面是患者使用本发明药物的临床统计资料:
一、一般资料
收治门诊患者240例,将患者随机分为观察组和对照组各120例,其中男性200例,女性40例,男女比例5:1,最大年龄66岁,最小年龄28岁,病程几月到几年不等。两组患者年龄、性别、病程等各项基本资料基本相同,差异无统计学意义(P>0.05)。
二、 诊断标准
肾小管浓缩功能障碍表现(夜尿多、低比重及低渗透压尿 ),当肾小球缺血病变发生后,尿化验出现异常(轻度蛋白尿,少量红细胞及管型), 肾小球功能渐进受损(内生肌配清除率下降,而后血清肌酐增高),并逐渐进展至终末期肾衰竭。与肾损害同时,常伴随出现高血压眼底病变及心、脑并发症。
三、治疗方法:
1、观察组按照本发明药物实施例一,称取原料药按发明实施方法治疗,取汤剂,饭后一小时内服用,每天三次。7天为一个疗程。
2、对照组采用常规西药卡托普利治疗,7天为一疗程。
四、疗效评定标准:
1、治愈:上述实验检查都正常,肾功能正常。
2、好转:偶尔有蛋白尿、少量红细胞,肾功能基本正常。
3、无效:上述实验检查均无明显改善或反加重者。
五、治疗结果统计:
对照组结果统计
使用该中药制剂两个疗程两组患者的疗效对比情况
其中:总有效率=治愈率+好转率
通过对比两组患者的治疗总有效率可以发现观察组明显高于对照组,由此说明,本发明中药在治疗小动脉性肾硬化症上具有良好的临床效果,能有效提高治疗的治愈率,效果显著,价格低廉,无不良反应和任何毒副作用,具有广阔的市场应用前景。
典型病例及疗效:
病例一、患者王某,男,36岁,青岛市人,2010年1月20日来我处就诊。经诊断结果如下:夜尿多、尿低比重,有轻度蛋白尿,以及有轻微的高血压眼底病变。确诊为小动脉性肾硬化症。采用本发明实施例一中所制制剂,以及所选的制备方法,在治疗二个疗程后,效果甚好,肾功能完全或基本恢复,电话随访半年未复发。
病例二、患者李某,男,42岁,山东临沂人。2010年5月14日来我处就诊,经诊断症状如下:夜尿多、同时伴有低渗透压尿,,尿化验有轻度蛋白尿和少量红细胞,并出现高血压眼底病变。确诊为小动脉性肾硬化症。采用本发明实施例一中所制制剂,以及所选的制备方法,在治疗二个疗程后,效果甚好,肾功能完全恢复,电话随访半年未复发。
Claims (4)
1.一种用于小动脉性肾硬化症的中药制剂,其特征在于,该中药制剂是由以下重量份的药物制成:桃仁10-14份、红花9-7-11份、当归16-20份、菟丝子18-22份、枸杞子18-22份、赤芍13-17份、川芎13-17份、丹参22-26份、益母草13-20份、三七粉1-5份、黄芪28-32份、白茅根22-26份、土茯苓16-20份、川牛膝13-17份、冬虫夏草1-5份、水蛭4-8份、沙苑子13-17份、续断18-22份、补骨脂16-20份、桂枝13-17份、萹蓄16-20份、泽兰13-17份、炙甘草7-11份。
2. 根据权利要求1所述的用于小动脉性肾硬化症的中药制剂,其特征在于,由以下重量份的药物制成:桃仁12份、红花9份、当归18份、菟丝子20份、枸杞子20份、赤芍15份、川芎15份、丹参24份、益母草18份、三七粉3份、黄芪30份、白茅根24份、土茯苓18份、川牛膝15份、冬虫夏草3份、水蛭6份、沙苑子15份、续断20份、补骨脂18份、桂枝15份、萹蓄18份、泽兰15份、炙甘草9份。
3.根据权利要求1或2所述的用于小动脉性肾硬化症的中药制剂,其特征在于:所述中药制剂为汤剂。
4.一种用于小动脉性肾硬化症的中药制剂的制备方法,其特征在于,制备方法如下:步骤一:按本发明重量份配比,取三七粉,粉碎,过200目筛,备用;步骤二:按本发明重量份配比,取冬虫夏草放入容器中,加入3倍体积的水,武火熬煮40-50分钟后,转文火熬煮10-20分钟,过滤滤液,反复三次,合并滤液,备用; 步骤三:按本发明重量配比,取枸杞子、赤芍、丹参、黄芪、白茅根、土茯苓、川牛膝、水蛭、续断、桂枝、萹蓄、泽兰、炙甘草药材置于砂锅中,加入8倍体积的水,武火熬煮20-30分钟后,加入红花、当归、川芎、益母草、补骨脂及分别用纱布包扎好的沙苑子、桃仁、菟丝子,武火熬煮10-20分钟,转文火熬煮30~40分钟得滤液,反复熬煮三次合并所得滤液,备用;步骤四:将步骤二、三所得滤液趁热冲服步骤一所得粉末,搅匀,既得本发明所述的治疗小动脉性肾硬化症的汤剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510335673.7A CN104873854A (zh) | 2015-06-17 | 2015-06-17 | 一种用于小动脉性肾硬化症的中药制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510335673.7A CN104873854A (zh) | 2015-06-17 | 2015-06-17 | 一种用于小动脉性肾硬化症的中药制剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104873854A true CN104873854A (zh) | 2015-09-02 |
Family
ID=53941709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510335673.7A Pending CN104873854A (zh) | 2015-06-17 | 2015-06-17 | 一种用于小动脉性肾硬化症的中药制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104873854A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106215095A (zh) * | 2016-08-11 | 2016-12-14 | 张绪伟 | 治疗肾虚血瘀证型前列腺增生的中药制剂 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101095936A (zh) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | 治疗肾动脉硬化的中药制剂 |
CN101095871A (zh) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | 治疗肾动脉硬化的一种中药 |
-
2015
- 2015-06-17 CN CN201510335673.7A patent/CN104873854A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101095936A (zh) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | 治疗肾动脉硬化的中药制剂 |
CN101095871A (zh) * | 2007-07-05 | 2008-01-02 | 北京艺信堂医药研究所 | 治疗肾动脉硬化的一种中药 |
Non-Patent Citations (2)
Title |
---|
左琪: "杨霓芝治疗良性小动脉性肾硬化经验", 《中医杂志》 * |
张立祥 等: "良性小动脉性肾硬化分期的辩证论治", 《实用中医内科杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106215095A (zh) * | 2016-08-11 | 2016-12-14 | 张绪伟 | 治疗肾虚血瘀证型前列腺增生的中药制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109966462A (zh) | 一种调理体质的膏方及其制备方法 | |
CN104352776A (zh) | 一种治疗月经过少致不孕的中药制剂及其制备方法 | |
CN104998129A (zh) | 一种用于蛛网膜下腔出血的中药制剂及其制备方法 | |
CN104825963A (zh) | 一种用于习惯性流产的中药制剂及其制备方法 | |
CN104225166A (zh) | 一种治疗闭经的中药组合物及其制备方法 | |
CN101485867B (zh) | 一种治疗静脉曲张的中药组合物及其制备方法 | |
CN104826074A (zh) | 一种用于窦性心动过缓的中药制剂及其制备方法 | |
CN104922538A (zh) | 一种用于IgA肾病中药制剂及其制备方法 | |
CN104984027A (zh) | 一种治疗骨髓增生异常综合征的中药制剂及其制备方法 | |
CN104857455A (zh) | 一种用于慢性间质性肾病中药制剂及其制备方法 | |
CN103330820B (zh) | 一种辅助治疗脓毒血症的中药组合物 | |
CN106362120A (zh) | 一种治疗高血糖和糖尿病的中药方剂 | |
CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
CN104888042A (zh) | 一种用于产后恶露不绝病的中药制剂及其制备方法 | |
CN104873854A (zh) | 一种用于小动脉性肾硬化症的中药制剂及其制备方法 | |
CN104840891A (zh) | 一种用于酒精性心肌病的中药制剂及其制备方法 | |
CN104857370A (zh) | 一种治疗乳腺癌症的中药组合物 | |
CN104173775A (zh) | 颈源性头痛中药组合物及制备方法 | |
CN104587443A (zh) | 一种用于原发性抗磷脂综合症的中药制剂及制备方法 | |
CN104547553A (zh) | 一种治疗神经性内分泌紊乱的中药 | |
CN109700969A (zh) | 一种治疗肝病的中药组合物及应用 | |
CN105878901A (zh) | 一种用于治疗乳腺癌术后皮瓣坏死的中药制剂及制备方法 | |
CN105311527A (zh) | 一种用于治疗子宫内膜移位症的中药制剂及其制备方法 | |
CN104922595A (zh) | 一种用于带状疱疹的中药制剂及其制备方法 | |
CN105250618A (zh) | 一种治疗肝硬化的抗病毒中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150902 |
|
RJ01 | Rejection of invention patent application after publication |